Outset Medical, Inc. (OM): Cost of Revenue
$72.72M
Year ended 2025-12-31
$68.61M
Trailing 12 months to 2026-06-30
-9.3%
3-year compound annual growth
+2.9%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $72.72M | -3.2% | 2026-02-13, From 2025-01-01 |
| 2024-12-31 | $75.12M | -25.9% | 2026-02-13, From 2024-01-01 |
| 2023-12-31 | $101.38M | +3.9% | 2026-02-13, From 2023-01-01 |
| 2022-12-31 | $97.54M | +2.7% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $94.99M | +50.9% | 2024-02-21, From 2021-01-01 |
| 2020-12-31 | $62.97M | +91.5% | 2023-02-13, From 2020-01-01 |
| 2019-12-31 | $32.88M | +304.8% | 2022-02-23, From 2019-01-01 |
| 2018-12-31 | $8.12M | n/a | 2021-03-22, From 2018-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Outset Medical, Inc. (OM) | 2025-12-31 | $72.72M | -3.2% |
| Biolife Solutions Inc (BLFS) | 2025-12-31 | $34.10M | +38.9% |
| Vaso Corp (VASO) | 2025-12-31 | $34.42M | -0.8% |
| Ceribell, Inc. (CBLL) | 2025-12-31 | $10.79M | +24.1% |
| Electromed, Inc. (ELMD) | 2026-06-30 | $15.83M | +12.9% |
| Axogen, Inc. (AXGN) | 2025-12-31 | $57.85M | +27.5% |
| Iridex Corp (IRIX) | 2026-01-03 | $33.45M | +14.7% |
| InMode Ltd. (INMD) | 2025-12-31 | $79.53M | +2.3% |
| Stereotaxis, Inc. (STXS) | 2025-12-31 | $15.31M | +24.2% |
Compare OM, BLFS, VASO, CBLL side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗